Transcept Pharmaceuticals Inc (NASDAQ:TSPT) is a speciality pharmaceutical company focused on the development of products that address the therapeutic needs in the field of neuroscience. At present the company has a market capitalization of $66.3 million and an average daily volume of 150,580 shares. Also see: How Doing What Is Right Helped Build the Indian Financial System Transcept Pharmaceuticals offers deep value Currently, Transcept Pharmaceuticals Inc (NASDAQ:TSPT) offers deep value, as the company is trading below the value of its cash balance. Indeed, at the end of the fiscal third quarter, Transcept reported cash and short-term investments of just under…
Transcept Pharmaceuticals: Deep Value, Quick Return Possible
Sign up now and get our in-depth FREE e-books on famous investors like Klarman, Dalio, Schloss, Munger Rupert is a committed value investor and regularly writes and invests following the principles set out by Benjamin Graham. He is the editor and co-owner of Hidden Value Stocks, a quarterly investment newsletter aimed at institutional investors. Rupert owns shares in Berkshire Hathaway. Rupert holds qualifications from the Chartered Institute For Securities & Investment and the CFA Society of the UK. Rupert covers everything value investing for ValueWalk